Table 5.
Repeated doseb | 420 mg/kg bw/day
|
1071 mg/kg bw/day
|
2142 mg/kg bw/day
|
|||
---|---|---|---|---|---|---|
Adverse event | Male (n = 6) | Female (n = 6) | Male (n = 6) | Female (n = 6) | Male (n = 6) | Female (n = 6) |
Flatulence | 1 (mild) | – | – | – | 3 (mild) | 2 (mild) |
Nausea | – | 1 (mild) | – | – | 4 (mild) | 3 (mild) |
1 (mod.) | ||||||
Diarrhea | – | – | 1 (mild) | – | 3 (mild) | 1 (mild) |
1 (mod.) | 3 (mod.) | |||||
Constipation | – | – | – | – | 2 (mild) | 1 (mild) |
Vomiting | – | – | – | – | 1(mild) | 1 (mild) |
2 (mod.) | 2 (mod.) | |||||
1 (severe) | ||||||
Decreased appetite | – | – | 1 (mild) | – | – | – |
Abdominal distension | – | – | – | – | 6 (mild) | 3 (mild) |
Abdominal pain | – | – | – | – | 1 (mild) | 1 (mod.) |
Abdominal pain – lower | – | – | – | – | – | 1 (mild) |
Abdominal pain – upper | – | – | – | – | 1 (mild) | 2 (mild) |
1 (mod.) | ||||||
Occult blood positive | 1 (mild) | – | – | – | – | – |
Rhinitis | – | – | – | – | 2 (mild) | – |
Palpitations | – | – | – | – | 1 (mild) | 1 (mild) |
Chest pain | – | – | – | – | – | 1 (mod.) |
Dyspnoea | – | – | – | – | – | 1 (mod.) |
Dizziness | – | 1 (mild) | – | – | 4 (mild) | 1 (mild) |
Headache | – | – | – | – | 6 (mild) | 2 (mild) |
Euphoria | – | 1 (mild) | – | – | – | – |
Fatigue | – | – | – | – | 2 (mild) | 2 (mild) |
Lethargy | – | – | – | – | 1 (mild) | – |
Somnolence | – | – | – | – | – | 1 (mild) |
Insomnia | – | – | – | – | 1 (mild) | – |
Anxiety | – | – | – | – | 1 (mild) | – |
Number of participants reporting at least one AE | 2 | 2 | 1 | 0 | 6 | 6 |
Total number of AEs reportedc | 3 | 4 | 2 | 0 | 50 | 42 |
AE = adverse event; bw = body weight; mod. = moderate.
The number of individuals reporting the symptoms listed is provided.
Ketone monoesters were administered as three divided doses of 140 mg/kg bw, 357 mg/kg bw, and 714 mg/kg bw over the course of the day.
Includes repeat occurrences of the same adverse event in the same individual.